The National Aspergillosis Centre is part of the Manchester Fungal Infection Group (MFIG) who have just published an important paper in the very prestigious Nature Communications journal.
Sara Gago in Paul Bowyer’s lab has characterised a mutation carried by people that researchers have found make their airways stickier, thus enabling Aspergillus spores to stick and grow. The implications for infection (ABPA) are pretty clear and the group have already discovered that this mutation is common in people with ABPA (28% of patients in this study had this mutation). This leads us straight to thinking about screening out people who are prone to infection as they carry this gene mutation. We can then pay special attention to prevent them getting ABPA. What this means for people who already have ABPA is less clear, but certainly suggests another target for treatment.
Share this post
Latest News posts
Herd immunity to COVID-19 – is it achievable?
October 28, 2021
Walk and paint yourself back to health & wellbeing
October 14, 2021
Antifungal Drug Pipeline
October 8, 2021
Is it COVID or just a cold?
September 24, 2021
World Sepsis Day 2021
September 13, 2021
Aspergillosis and Depression: A Personal Reflection
September 1, 2021
Therapeutic drug monitoring (TDM)
August 9, 2021
When will there be a vaccine for aspergillosis?
July 16, 2021
Palliative Care – Not What You Might Think
June 15, 2021
News archive
- Antifungals in development
- COVID-19
- Events
- Fundraising
- General interest
- How do I...?
- Information and Learning
- Latest research news
- Lifestyle and Coping Skills
- Living with Aspergillosis
- NAC announcements
- News archive
- Patient and Carer Blog
- Patient stories
- Recordings
- Supplements and complementary therapies
- Types of aspergillosis
- Video